(Q37217409)

English

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

scientific article published on 16 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

0 references

Xavier Carbonell-Estrany

1

object named as

X Carbonell-Estrany

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

L Bont

2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

G Doering

3

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

J-B Gouyon

4

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

M Lanari

5

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

16 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

891-899

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

https://scigraph.springernature.com/pub.10.1007/s10096-008-0520-8

0 references

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0520-8

21 January 2018

Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0520-8

21 January 2018

Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and preterm infants

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0520-8

21 January 2018

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0520-8

21 January 2018

Human metapneumovirus in severe respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-008-0520-8

21 January 2018

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial. Northern Hemisphere Expanded Access Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of wheezing after respiratory syncytial virus infection on health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced lung function in healthy preterm infants in the first months of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recommendations for the prevention of respiratory syncytial virus infection]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for severe respiratory syncytial virus infection in infants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological mechanisms of severe respiratory syncytial virus bronchiolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RSV outbreak in a paediatric intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory morbidity 20 years after RSV infection in infancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lung growth in late gestation and in the neonate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic epidemiology and immunopathology of RSV in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teenage asthma after severe infantile bronchiolitis or pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of human metapneumovirus co-infection in cases of severe respiratory syncytial virus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum-gamma-G-globulin levels in normal premature, post-mature, and "small-for-dates" newborn babies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Births: final data for 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoprophylaxis of respiratory syncytial virus: global experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18629558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-008-0520-8

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37217409&oldid=2132143490"